Profile for South Korea Patent: 20160043954
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 20160043954
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,344,765 | Jun 27, 2034 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| 11,162,500 | Jun 27, 2034 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| 11,959,486 | Jun 27, 2034 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| 9,820,938 | Jun 27, 2034 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
